Athena Athena

X

Digital content for Forma Therapeutics

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Forma Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
300 North Beacon Street, Suite 501 Watertown, MA 02472
Telephone
Telephone
617.679.1970

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://endpts.com/novo-nordisk-offloads-preclinical-cancer-candidate-from-1-1b-forma-buyout-debiopharm/

Amber Tong ENDPTS
02 Mar 2023

https://www.biopharmadive.com/news/rigel-pharmaceuticals-leukemia-rezlidhia-fda-approval/637843/

Christopher Newman BIOPHARMADIVE
03 Dec 2022

https://www.globenewswire.com/news-release/2022/10/14/2534660/0/en/Novo-Nordisk-announces-the-completion-of-the-Forma-Therapeutics-acquisition.html

GLOBENEWSWIRE
14 Oct 2022

https://ir.formatherapeutics.com/news-releases/news-release-details/novo-nordisk-acquire-forma-therapeutics-and-expand-presence

PRESS RELEASE
01 Sep 2022

https://www.businesswire.com/news/home/20220805005036/en

BUSINESSWIRE
05 Aug 2022

https://www.prnewswire.com/news-releases/rigel-pharmaceuticals-and-forma-therapeutics-announce-licensing-agreement-for-olutasidenib-a-novel-mutant-idh1-inhibitor-for-the-potential-treatment-of-relapsed-or-refractory-acute-myeloid-leukemia-301598297.html

PRNEWSWIRE
02 Aug 2022

https://www.fiercebiotech.com/biotech/rigel-hands-over-2m-formas-cancer-drug-awaits-fda-approval-decision

Gabrielle Masson FIERCEBIOTECH
02 Aug 2022

https://www.businesswire.com/news/home/20220729005060/en

BUSINESSWIRE
29 Jul 2022

https://www.businesswire.com/news/home/20220630005268/en

BUSINESSWIRE
30 Jun 2022

https://www.businesswire.com/news/home/20220610005055/en

BUSINESSWIRE
10 Jun 2022
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY